Tutorials › Nonlinear Mixed-Effects Models (NLME) › Staged Fitting To Stabilize Complex NLME Models

Estimation Failures and Troubleshooting · Tutorial 273 of 797

Staged Fitting To Stabilize Complex NLME Models

Build a complex NLME model progressively, using objective changes and parameter stability to guide—but not replace—assessment of the final fit.

Advanced 11 min read

What You'll Learn

  • Define a staged fitting sequence for a nonlinear mixed-effects model.
  • Explain when objective-function comparisons across stages are meaningful.
  • Calculate objective changes and relative parameter shifts from hypothetical fits.
  • Use a random-effects sequence that adds variability before correlation complexity.
  • Recognize why warm starts help optimization but do not establish final estimates.
  • Identify warning signs that a staged fit needs investigation rather than acceptance.

Why Fit a Complex NLME Model in Stages?

A complex nonlinear mixed-effects (NLME) model may ask an optimizer to estimate structural parameters, residual-error parameters, random-effect variances, and perhaps correlations all at once. These components can interact: for example, a change in the residual model can alter the structural estimates, while adding between-subject variability can change how the model explains individual concentration profiles. If the initial parameter values are poor, the optimizer may struggle to find a useful solution.

Staged fitting is a practical way to organize estimation. Begin with a simpler working model that gives stable structural estimates, then add model components in a planned sequence. Use each stage’s estimates as starting values for the next, and inspect both the objective function and parameter changes. The intermediate fits are guides to estimation, not substitutes for the final model or evidence that its assumptions are adequate.

Definition: Staged fitting is a sequence of related model fits in which the model begins with a relatively simple structure and gains specified residual-error or random-effect components over successive stages. Estimates from one stage may initialize the next stage. The final reported estimates must come from fitting the intended final model, with all parameters that are intended to be estimated released for estimation.

Model and Conditions for Comparing Stages

For subject \(i\) at observation time \(t_{ij}\), a general NLME observation model can be written as

$$ y_{ij}=f(t_{ij},\theta,b_i)+\varepsilon_{ij}. $$

Here, \(y_{ij}\) is the observed response, \(f\) is the structural model, \(\theta\) denotes population structural parameters, and \(b_i\) is the subject-specific random effect. A common working assumption is \(b_i\sim N(0,\Omega)\), with independent random effects across subjects. Conditional on \(b_i\), the residual vector for subject \(i\) has mean zero and a specified covariance matrix \(R_i\); residuals are commonly assumed independent across subjects and independent of the random effects. The residual model specifies how \(R_i\) depends on the predicted response and residual-error parameters.

The likelihood for one subject is obtained by integrating over that subject’s random effects:

$$ L_i(\theta,\Omega,\psi)=\int p(y_i\mid b_i;\theta,\psi)\,p(b_i;\Omega)\,db_i, \qquad \ell=\sum_i \log L_i, \qquad \mathrm{OFV}=-2\ell, $$

where \(y_i\) denotes that subject’s observations and \(\psi\) denotes residual-error parameters. In practice, the likelihood may be evaluated using an approximation or numerical method. When comparing objective values across stages, keep the observations, data handling, likelihood definition, and objective-function convention the same. An objective difference is not interpretable as a model improvement if, for example, one stage uses a different set of records or a different likelihood.

A useful staged sequence starts with the intended structural model and a simple, defensible residual model. It then adds residual-error flexibility if needed, followed by random-effect variances in a controlled order. If subject variability is part of the intended final model, a fit with no random effects is only an initialization step: it cannot account for that heterogeneity.

Why the Objective Can Decrease—and What That Does Not Prove

For nested models fitted to the same data with the same likelihood, the more flexible model can reproduce every parameter setting available to the simpler model. If each fit reaches its global maximum, the maximized log likelihood cannot be lower for the expanded model. Since the objective is \(-2\ell\), its minimized value cannot be higher. This is a property of the likelihood maximization problem, not a guarantee about the behavior of a numerical optimizer.

For example, adding a proportional residual component to an additive-error model can be nested by setting the proportional component to zero. Adding a random-effect variance can recover the no-random-effect model at zero variance, understood as a limiting or degenerate case. But a reduced model created by fixing parameters at arbitrary values may not be nested in the intended way. Nor does a lower objective by itself show that the expanded model is scientifically appropriate, adequately identified, or well estimated. Variance parameters on boundaries also require care: a routine chi-square reference for an objective difference is not automatically valid.

Justification: Let \(\Theta_0\) be the parameter space of a simpler model and \(\Theta_1\) the parameter space of a nested expanded model, with \(\Theta_0\subseteq\Theta_1\). Then \(\sup_{\Theta_1}\ell\geq\sup_{\Theta_0}\ell\), so \(-2\sup_{\Theta_1}\ell\leq-2\sup_{\Theta_0}\ell\). In actual staged fitting, numerical optimization may stop short of either supremum, so an unexpected objective increase is a reason to investigate the fit, not proof that the nesting result is false.

A Practical Staging Strategy

A stage should add a defined component, not several unrelated changes at once. A typical sequence is: fit the structural model with a simple residual model; consider a more flexible residual model while holding the structural form fixed; add random-effect variances for selected parameters; and only then consider more elaborate random-effect covariance structure if justified by the model and data. The order should reflect the scientific model and the information in the data, not a desire to make every objective decrease.

1
Set up a stable working fit.
Use the intended structural model, consistent data handling, a reasonable residual model, and plausible starting values. Treat this as a source of initial estimates, not necessarily as the final population model.
2
Add residual flexibility if warranted.
For example, move from additive error to combined additive and proportional error. Check that the new component has a meaningful scale and that the structural estimates remain interpretable.
3
Add random-effect variances deliberately.
Begin with variability on parameters for which subject-level differences are scientifically plausible and supported by the sampling design. Avoid introducing many variances and correlations simultaneously.
4
Refit the intended final model.
Release all parameters intended for estimation and assess the resulting estimates, objective, and fit diagnostics. Do not report an intermediate fit whose parameters were fixed only to help initialize later stages.

At each step, record the objective value, the parameter estimates, whether the fit reached its stated stopping condition, and any estimates that approach constraints or bounds. Parameter stability means that estimates do not change substantially without explanation when a planned component is added. It is a diagnostic judgment, not a universal percentage cutoff. A large shift may be a real consequence of changing the model, or it may signal weak identification, an inadequate starting point, or an unstable optimization.

Worked Example: Tracking Objective Changes Across Three Stages

Hypothetical data and model. Suppose concentrations after an intravenous bolus are described by \(C(t)=D/V\,\exp(-kt)\), where \(D\) is dose, \(V\) is volume in litres, and \(k\) is the elimination rate constant in inverse hours. The working residual model is additive normal error. Stage 2 adds proportional error, giving residual variance \(\sigma_{\mathrm{add}}^2+(\sigma_{\mathrm{prop}}C(t))^2\). Stage 3 adds random effects on log volume and log elimination rate. Assume each stage uses the same records and likelihood convention.

The hypothetical fitted results are:

StageModel changeOFVSelected estimates
1Structural model; additive error512.4\(V=20.0\) L; \(k=0.180\) h\(^{-1}\)
2Add proportional residual error486.1\(V=20.7\) L; \(k=0.176\) h\(^{-1}\); \(\sigma_{\mathrm{prop}}=0.12\)
3Add random effects on log \(V\) and log \(k\)451.7\(V=21.3\) L; \(k=0.170\) h\(^{-1}\); random-effect SDs \(0.22\) and \(0.18\)

From Stage 1 to Stage 2, the objective decreases by \(512.4-486.1=26.3\). From Stage 2 to Stage 3, it decreases by \(486.1-451.7=34.4\). The total decrease is \(512.4-451.7=60.7\). These calculations describe changes in the fitted objective; they do not, by themselves, establish that every added component is useful or that the final estimates are reliable.

The structural estimates also shift as the model becomes more flexible. For instance, the Stage 2 to Stage 3 relative change in \(V\), measured against its Stage 2 value, is \((21.3-20.7)/20.7\times100=2.90\%\). That modest change is not automatically evidence of stability: the analyst must also consider uncertainty, model adequacy, and whether the change is scientifically plausible. The stages provide a traceable path to the final model rather than a test that can be passed by a particular numerical threshold.

Adding Random Effects Without Losing the Thread

Random-effect variances can be introduced one at a time or in small, planned groups. If the final model requires variability in more than one parameter, first estimate a simpler random-effects structure, then add the next variance while retaining the same structural and residual models. Correlations are additional parameters and can make estimation more demanding; a parsimonious sequence generally introduces them only after the relevant variances have been considered.

This sequence helps locate which addition coincides with a major change in the objective or in other estimates. It does not prove that a particular random effect is identifiable, nor does it justify retaining a component solely because the objective fell. When a variance approaches zero or another bound, inspect whether the data support that component and whether the estimate is sensitive to reasonable modeling choices. A boundary value is a diagnostic clue, not a reason to force a positive variance.

Worked Example: Adding Random-Effect Variances Sequentially

Hypothetical results. Suppose a two-parameter structural model is fitted with the same combined residual-error model at every stage. Stage A has no random effects and OFV \(486.1\). Stage B adds a random effect on log \(V\) and has OFV \(463.8\). Stage C retains that effect and adds one on log \(k\), giving OFV \(451.7\). The estimated random-effect standard deviations in Stage C are \(0.22\) for log \(V\) and \(0.18\) for log \(k\).

The objective decreases by \(486.1-463.8=22.3\) when variability in log \(V\) is added, and by \(463.8-451.7=12.1\) when variability in log \(k\) is added. If the standard deviations are on the log scale, they are dimensionless. These changes show how the fitted objective responds to the specified additions, but no p-value or model-selection conclusion follows from the arithmetic alone. The variance estimates, their uncertainty, diagnostics, and scientific rationale still matter.

If the second addition instead produced OFV \(470.0\), the objective would have increased by \(470.0-463.8=6.2\). Under a genuinely nested likelihood fit at the global maximum, that ordering would be unexpected. It would prompt a check that the records and likelihood are identical, that the intended parameters were actually estimated, and that the optimization completed as intended. It would not be sound to report the increased objective as evidence that the nested model has a worse theoretical maximum.

Parameter Stability, Failure Modes, and Alternatives

Staged fitting is most informative when the analyst compares more than the objective. Track structural estimates, residual scales, random-effect variances, and predictions at representative times. If adding a residual component changes the structural estimates sharply, the earlier structural fit may have been compensating for a misspecified error model. If adding random effects produces large shifts, that may reflect newly represented between-subject variability, but it can also indicate that the data do not distinguish the components well.

  • Objective increases unexpectedly. Verify that the data, likelihood, and objective convention are unchanged and that the expanded fit actually converged to a comparable solution.
  • Estimates jump or hit bounds. Review the model specification, parameter scales, starting values, and whether the data contain information about the added component. Do not hide the change by fixing the estimate at its earlier value.
  • Objective decreases but fit remains implausible. A more flexible model can improve the likelihood while retaining systematic residual patterns or implausible parameter estimates. Inspect model predictions and residual behavior as well as the objective.
  • Intermediate estimates are mistaken for final estimates. Parameters fixed to stabilize an early stage have not been estimated freely in the final model. Release the intended parameters and fit that model before interpreting its estimates.

A one-shot simultaneous fit has the advantage that it targets the full model directly, but it can be sensitive to initialization when many components interact. Staging provides interpretable checkpoints and usable warm starts, but it does not guarantee convergence or remove weak identification. Permanently fixing estimates from a simpler model can make later optimization easier, but it changes the final inferential problem and can understate uncertainty; it is not equivalent to staged initialization. The appropriate alternative depends on the model and data, and the final fit must correspond to the model the analyst intends to use.

Key takeaway: Use stages to build a stable path to the intended full model. Compare objective values only under consistent likelihood conditions, track parameter changes at every addition, and base conclusions on the freely estimated final model and its diagnostics—not on a decreasing objective alone.

Check Your Understanding

Answer each question, then compare with the brief solutions.

  1. A simpler fit has OFV \(320.5\), and a nested expanded fit has OFV \(309.2\), using the same observations and likelihood. What is the objective decrease, and what can it establish?
  2. Why is a fit with no random effects generally an initialization model rather than a final model when the intended model includes between-subject variability?
  3. A random-effect addition gives a higher objective than the preceding fit. Name two checks to make before interpreting this result.
  4. Why should estimates from a stage in which parameters were fixed not be treated as freely estimated final-model estimates?

Solutions. (1) The decrease is \(320.5-309.2=11.3\). It describes the change in the fitted objective; alone it does not establish adequacy, identifiability, or a significance result. (2) The no-random-effect fit cannot represent the intended subject-level heterogeneity, so its estimates serve as starting values for the expanded model. (3) Check that the same records, likelihood, and objective convention were used, and verify that the expanded fit completed as intended with the added parameters actually estimated. (4) Fixed parameters were not allowed to adjust in that fit; their values are constraints from the staging process, not estimates obtained by freely fitting the final model.